CORCEPT THERAPEUTICS INC
CORT
84 insider filings · Latest: Oct 15, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Aug 14, 2026 | Aug 18 8:30 PM | Sean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission. | Sale | 3,664 | $114.49 | $419.5K | 9,755(D) | View → |
| Aug 14, 2026 | Aug 18 8:30 PM | James N WilsonDirector | Sale | 10,000 | $111.43 | $1.1M | 1,074,543(I) | View → |
| Aug 17, 2026 | Aug 18 8:30 PM | Gary Charles RobbChief Business Officer | Sale | 10,000 | $116.26 | $1.2M | 39,716(I) | View → |
| Aug 18, 2026 | Aug 18 2:12 PM | MAHONEY DAVID L | Proposed Sale | 103,606 | $117.37 | $12.2M | — | View → |
| Aug 17, 2026 | Aug 17 8:05 PM | Robb Gary Charles | Proposed Sale | 10,000 | $116.26 | $1.2M | — | View → |
| Aug 10, 2026 | Aug 12 8:27 PM | Sean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission. | Sale | 1,031 | $114.52 | $118.1K | 9,755(D) | View → |
| Aug 10, 2026 | Aug 12 8:26 PM | William GuyerChief Development Officer | Sale | 16,300 | $113.43 | $1.8M | 3,985(D) | View → |
| Aug 4, 2026 | Aug 6 10:44 PM | William GuyerChief Development Officer | Sale | 3,700 | $113.12 | $418.6K | 3,985(D) | View → |
| Aug 3, 2026 | Aug 5 9:51 PM | Sean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission. | Sale | 20,305 | $114.70 | $2.3M | 9,755(D) | View → |
| Aug 3, 2026 | Aug 5 9:48 PM | Joseph Douglas LyonChief Accounting & Technology Officer | Sale | 1,540 | $114.16 | $175.8K | 5,495(D) | View → |
| Aug 4, 2026 | Aug 4 7:07 PM | Guyer William | Proposed Sale | 20,000 | $112.80 | $2.3M | — | View → |
| Jul 30, 2026 | Aug 3 8:30 PM | Atabak MokariChief Financial Officer | Sale | 80,000 | $114.71 | $9.2M | 16,130(D) | View → |
| Aug 3, 2026 | Aug 3 4:16 PM | Lyon Joseph Douglas | Proposed Sale | 1,540 | $114.16 | $175.8K | — | View → |
| Jul 30, 2026 | Jul 30 8:03 PM | Mokari Atabak | Proposed Sale | 40,000 | $114.71 | $4.6M | — | View → |
| Jul 15, 2026 | Jul 17 10:38 PM | James N WilsonDirector | Sale | 10,000 | $88.30 | $883.0K | 1,084,543(I) | View → |
| Jul 15, 2026 | Jul 17 10:31 PM | Atabak MokariChief Financial Officer | Sale | 40,000 | $87.71 | $3.5M | 16,130(D) | View → |
| Jul 7, 2026 | Jul 8 11:54 PM | William GuyerChief Development Officer | Sale | 20,000 | $93.13 | $1.9M | 3,985(D) | View → |
| Jul 7, 2026 | Jul 7 3:12 PM | Guyer William | Proposed Sale | 20,000 | $93.13 | $1.9M | — | View → |
| Jul 1, 2026 | Jul 6 8:44 PM | Sean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission. | Sale | 25,000 | $88.35 | $2.2M | 9,755(D) | View → |
| Jun 16, 2026 | Jun 18 8:30 PM | James N WilsonDirector | Sale | 10,000 | $83.20 | $832.0K | 1,094,543(I) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Oct 2, 2026 | Oct 5 11:58 PM | Roberto Wandenkolk VieiraPresident, Oncology | Option Exercise | 8,333 | $21.63 | 133,334(D) | View → |
| Oct 2, 2026 | Oct 5 11:54 PM | Joseph Douglas LyonChief Accounting & Technology Officer | Option Exercise | 9,190 | $19.26 | 44,167(D) | View → |
| Oct 1, 2026 | Oct 5 11:54 PM | Joseph Douglas LyonChief Accounting & Technology Officer | Option Exercise | 810 | $13.56 | 3,357(D) | View → |
| Oct 2, 2026 | Oct 5 11:49 PM | Sean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission. | Option Exercise | 24,587 | $8.27 | 41,986(D) | View → |
| Oct 1, 2026 | Oct 5 11:49 PM | Sean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission. | Option Exercise | 413 | $8.27 | 66,573(D) | View → |
| Oct 1, 2026 | Oct 5 11:44 PM | Justin Frederick GunnPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission. | Grant/Award | 100,000 | $114.03 | 100,000(D) | View → |
| Sep 17, 2026 | Sep 18 11:47 PM | Gary Charles RobbChief Business Officer | Option Exercise | 17,493 | $8.27 | 182,507(D) | View → |
| Sep 14, 2026 | Sep 16 8:30 PM | Joseph Douglas LyonChief Accounting & Technology Officer | Option Exercise | 10,000 | $13.56 | 4,167(D) | View → |
| Sep 1, 2026 | Sep 4 1:16 AM | Sean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission. | Option Exercise | 25,000 | $8.27 | 66,986(D) | View → |
| Sep 2, 2026 | Sep 4 1:02 AM | Roberto Wandenkolk VieiraPresident, Oncology | Option Exercise | 58,333 | $21.63 | 141,667(D) | View → |
| Aug 26, 2026 | Aug 28 8:30 PM | Kimberly ParkDirector | Option Exercise | 30,000 | $13.49 | 30,000(D) | View → |
| Aug 25, 2026 | Aug 27 8:30 PM | Sean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission. | Option Exercise | 30,955 | $11.35 | 169,045(D) | View → |
| Aug 14, 2026 | Aug 18 8:30 PM | Sean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission. | Option Exercise | 3,664 | $8.27 | 91,986(D) | View → |
| Aug 10, 2026 | Aug 12 8:27 PM | Sean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission. | Option Exercise | 1,031 | $8.27 | 95,650(D) | View → |
| Aug 10, 2026 | Aug 12 8:26 PM | William GuyerChief Development Officer | Option Exercise | 16,300 | $21.65 | 110,000(D) | View → |
| Aug 4, 2026 | Aug 6 10:44 PM | William GuyerChief Development Officer | Option Exercise | 3,700 | $21.65 | 126,300(D) | View → |
| Aug 3, 2026 | Aug 5 9:51 PM | Sean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission. | Option Exercise | 20,305 | $8.27 | 96,681(D) | View → |
| Jul 30, 2026 | Aug 3 8:30 PM | Atabak MokariChief Financial Officer | Option Exercise | 80,000 | $23.06 | 95,833(D) | View → |
| Jul 15, 2026 | Jul 17 10:31 PM | Atabak MokariChief Financial Officer | Option Exercise | 40,000 | $23.06 | 175,833(D) | View → |
| Jul 7, 2026 | Jul 8 11:54 PM | William GuyerChief Development Officer | Option Exercise | 20,000 | $21.65 | 130,000(D) | View → |
Page 1 of 3
Next →